Aggrenox® (Extended-Release Dipyridamole and Low-Dose Aspirin in Combination): Protecting Platelets from Excessive Activation in Patients with Vascular Events

Publisher： Karger

E-ISSN： 1424-0556|2|2|93-104

ISSN： 1422-9528

Source： Heart Drug, Vol.2, Iss.2, 2002-06, pp. : 93-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended-Release Dipyridamole/Aspirin

By Hervey P.S.   Goa K.L.  

Drugs, Vol. 58, Iss. 3, 1999-09 ,pp. : 469-475

Adis International

Access to resources Recommend Favorite

Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin

By Ye Yumei   Long Bo   Qian Jinqiao   Perez-Polo Jose   Birnbaum Yochai  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 391-399

Springer Publishing Company

Access to resources Recommend Favorite

Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly: Aspirin in Reducing Events in the Elderly (ASPREE)

By Nelson M.R.   Reid C.M.  

Drugs & Aging, Vol. 20, Iss. 12, 2003-01 ,pp. : 897-903

Adis International

Access to resources Recommend Favorite

Non-compliance and discontinuation increases the risk of cardiovascular events in patients receiving low-dose aspirin

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 11, 2010-11 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Ramipril/felodipine extended-release fixed-dose combination: a guide to its use in essential hypertension

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 9, 2007-09 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite